Some risks of compounded semaglutide include dosing errors (which can lead to serious side effects), contamination, and illegal sales of counterfeit products, which could be harmful
it is not a direct side effect of the medication itself
By Manuel Bowman Fact-checked by Payton Olsen Last updated June 2026
Understanding tirzepatide dose-response for informed conversion decisions Knowing the conversion math is only half the picture
J Mol Neurosci 46:236247 Shukla A, Bhardwaj U, Apoorva, Seth P, Singh SK (2024) Hypoxia-induced miR-101 impairs endothelial barrier integrity through altering VE-cadherin and claudin-5
Hiromichi Wakui has received research supports from AstraZeneca, Otsuka Pharmaceutical, and Kaneka Corporation, and honoraria from AstraZeneca, Otsuka Pharmaceutical, Kaneka Corporation, Kyowa Kirin, Sanwa Kagaku, Chugai Pharma, Kowa, Otsuka Pharmaceutical, Novartes, Mitsubishi-Tanabe Pharma, Bayer, and Daiichi-Sankyo Pharma